 | • レポートコード：QYR9ST02947 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の髄膜炎菌性疾患治療市場について調査・分析し、以下の構成でお届け致します。髄膜炎菌性疾患治療の種類別には、抗生物質、ワクチンに、用途別には、病院、ドラッグストア、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別髄膜炎菌性疾患治療売上データ ・地域別髄膜炎菌性疾患治療市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別髄膜炎菌性疾患治療市場規模：抗生物質、ワクチン ・用途別髄膜炎菌性疾患治療市場規模：病院、ドラッグストア、その他 ・主要メーカーの企業情報：Pfizer、GlaxoSmithKline、Sanofi Pasteur、Novartis ・髄膜炎菌性疾患治療の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Meningococcal disease is a severe infection of meninges, the thin layers of tissue covering brain and spinal cord, caused by the bacteria Neisseria meningitidis. This bacteria can also cause bloodstream infections (septicemia). Bacterial meningitis is severe because of rapid onset and a significant risk of death associated with infection. Infection of Neisseria meningitidis may also result in mental retardation, deafness and epilepsy. 12 strains of N. meningitidis have been identified, 6 of which (A, B, C, W, X and Y) are capable enough to cause epidemics. Meningococcal septicaemia is a rare but fatal form of meningococcal disease characterized by a haemorrhagic rash and rapid circulatory collapse.The global Meningococcal Disease Treatment market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Meningococcal Disease Treatment market based on company, product type, end user and key regions.
This report studies the global market size of Meningococcal Disease Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Meningococcal Disease Treatment in these regions.
This research report categorizes the global Meningococcal Disease Treatment market by top players/brands, region, type and end user. This report also studies the global Meningococcal Disease Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
GlaxoSmithKline
Sanofi Pasteur
Novartis
Market size by Product
Antibiotics
Vaccines
Market size by End User
Hospitals
Drugstores
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Meningococcal Disease Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Meningococcal Disease Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Meningococcal Disease Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Meningococcal Disease Treatment submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Meningococcal Disease Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Meningococcal Disease Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Meningococcal Disease Treatment Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Meningococcal Disease Treatment Market Size Growth Rate by Product
1.4.2 Antibiotics
1.4.3 Vaccines
1.5 Market by End User
1.5.1 Global Meningococcal Disease Treatment Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Drugstores
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Meningococcal Disease Treatment Market Size
2.1.1 Global Meningococcal Disease Treatment Revenue 2014-2025
2.1.2 Global Meningococcal Disease Treatment Sales 2014-2025
2.2 Meningococcal Disease Treatment Growth Rate by Regions
2.2.1 Global Meningococcal Disease Treatment Sales by Regions
2.2.2 Global Meningococcal Disease Treatment Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Meningococcal Disease Treatment Sales by Manufacturers
3.1.1 Meningococcal Disease Treatment Sales by Manufacturers
3.1.2 Meningococcal Disease Treatment Sales Market Share by Manufacturers
3.1.3 Global Meningococcal Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Meningococcal Disease Treatment Revenue by Manufacturers
3.2.1 Meningococcal Disease Treatment Revenue by Manufacturers (2014-2019)
3.2.2 Meningococcal Disease Treatment Revenue Share by Manufacturers (2014-2019)
3.3 Meningococcal Disease Treatment Price by Manufacturers
3.4 Meningococcal Disease Treatment Manufacturing Base Distribution, Product Types
3.4.1 Meningococcal Disease Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Meningococcal Disease Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Meningococcal Disease Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Meningococcal Disease Treatment Sales by Product
4.2 Global Meningococcal Disease Treatment Revenue by Product
4.3 Meningococcal Disease Treatment Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Meningococcal Disease Treatment Breakdown Data by End User
6 North America
6.1 North America Meningococcal Disease Treatment by Countries
6.1.1 North America Meningococcal Disease Treatment Sales by Countries
6.1.2 North America Meningococcal Disease Treatment Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Meningococcal Disease Treatment by Product
6.3 North America Meningococcal Disease Treatment by End User
7 Europe
7.1 Europe Meningococcal Disease Treatment by Countries
7.1.1 Europe Meningococcal Disease Treatment Sales by Countries
7.1.2 Europe Meningococcal Disease Treatment Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Meningococcal Disease Treatment by Product
7.3 Europe Meningococcal Disease Treatment by End User
8 Asia Pacific
8.1 Asia Pacific Meningococcal Disease Treatment by Countries
8.1.1 Asia Pacific Meningococcal Disease Treatment Sales by Countries
8.1.2 Asia Pacific Meningococcal Disease Treatment Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Meningococcal Disease Treatment by Product
8.3 Asia Pacific Meningococcal Disease Treatment by End User
9 Central & South America
9.1 Central & South America Meningococcal Disease Treatment by Countries
9.1.1 Central & South America Meningococcal Disease Treatment Sales by Countries
9.1.2 Central & South America Meningococcal Disease Treatment Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Meningococcal Disease Treatment by Product
9.3 Central & South America Meningococcal Disease Treatment by End User
10 Middle East and Africa
10.1 Middle East and Africa Meningococcal Disease Treatment by Countries
10.1.1 Middle East and Africa Meningococcal Disease Treatment Sales by Countries
10.1.2 Middle East and Africa Meningococcal Disease Treatment Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Meningococcal Disease Treatment by Product
10.3 Middle East and Africa Meningococcal Disease Treatment by End User
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Business Overview
11.1.3 Pfizer Meningococcal Disease Treatment Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Pfizer Meningococcal Disease Treatment Products Offered
11.1.5 Pfizer Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 Company Business Overview
11.2.3 GlaxoSmithKline Meningococcal Disease Treatment Sales, Revenue and Gross Margin (2014-2019)
11.2.4 GlaxoSmithKline Meningococcal Disease Treatment Products Offered
11.2.5 GlaxoSmithKline Recent Development
11.3 Sanofi Pasteur
11.3.1 Sanofi Pasteur Company Details
11.3.2 Company Business Overview
11.3.3 Sanofi Pasteur Meningococcal Disease Treatment Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Sanofi Pasteur Meningococcal Disease Treatment Products Offered
11.3.5 Sanofi Pasteur Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Company Business Overview
11.4.3 Novartis Meningococcal Disease Treatment Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Novartis Meningococcal Disease Treatment Products Offered
11.4.5 Novartis Recent Development
12 Future Forecast
12.1 Meningococcal Disease Treatment Market Forecast by Regions
12.1.1 Global Meningococcal Disease Treatment Sales Forecast by Regions 2019-2025
12.1.2 Global Meningococcal Disease Treatment Revenue Forecast by Regions 2019-2025
12.2 Meningococcal Disease Treatment Market Forecast by Product
12.2.1 Global Meningococcal Disease Treatment Sales Forecast by Product 2019-2025
12.2.2 Global Meningococcal Disease Treatment Revenue Forecast by Product 2019-2025
12.3 Meningococcal Disease Treatment Market Forecast by End User
12.4 North America Meningococcal Disease Treatment Forecast
12.5 Europe Meningococcal Disease Treatment Forecast
12.6 Asia Pacific Meningococcal Disease Treatment Forecast
12.7 Central & South America Meningococcal Disease Treatment Forecast
12.8 Middle East and Africa Meningococcal Disease Treatment Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Meningococcal Disease Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Meningococcal Disease Treatment Product Picture
Table Meningococcal Disease Treatment Market Segments
Table Key Manufacturers Meningococcal Disease Treatment Covered
Table Global Meningococcal Disease Treatment Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Meningococcal Disease Treatment Sales Market Share by Product 2014-2025
Figure Antibiotics Product Picture
Table Major Manufacturers of Antibiotics
Figure Vaccines Product Picture
Table Major Manufacturers of Vaccines
Table Global Meningococcal Disease Treatment Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospitals
Figure Drugstores
Figure Others
Figure Meningococcal Disease Treatment Report Years Considered
Figure Global Meningococcal Disease Treatment Market Size 2014-2025 (Million US$)
Figure Global Meningococcal Disease Treatment Sales 2014-2025 (K Units)
Table Global Meningococcal Disease Treatment Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Meningococcal Disease Treatment Sales by Regions 2014-2019 (K Units)
Table Global Meningococcal Disease Treatment Sales Market Share by Regions 2014-2019
Figure Global Meningococcal Disease Treatment Sales Market Share by Regions 2014-2019
Figure 2018 Global Meningococcal Disease Treatment Sales Market Share by Regions
Table Global Meningococcal Disease Treatment Revenue by Regions 2014-2019 (Million US$)
Table Global Meningococcal Disease Treatment Revenue Market Share by Regions 2014-2019
Figure Global Meningococcal Disease Treatment Revenue Market Share by Regions 2014-2019
Figure 2018 Global Meningococcal Disease Treatment Revenue Market Share by Regions
Table Global Meningococcal Disease Treatment Sales by Manufacturers (2014-2019) (K Units)
Table Global Meningococcal Disease Treatment Sales Share by Manufacturers (2014-2019)
Figure Global Meningococcal Disease Treatment Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Meningococcal Disease Treatment Revenue by Manufacturers (2014-2019) (Million USD)
Table Meningococcal Disease Treatment Revenue Share by Manufacturers (2014-2019)
Figure Meningococcal Disease Treatment Value Share by Manufacturers in 2018
Table Key Manufacturers Meningococcal Disease Treatment Price (2014-2019) (USD/Unit)
Table Meningococcal Disease Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Meningococcal Disease Treatment Product Type
Table Date of International Manufacturers Enter into Meningococcal Disease Treatment Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Meningococcal Disease Treatment Sales by Product (2014-2019) (K Units)
Table Global Meningococcal Disease Treatment Sales Share by Product (2014-2019)
Figure Global Meningococcal Disease Treatment Sales Market Share by Product (2014-2019)
Figure Global Meningococcal Disease Treatment Sales Market Share by Product in 2018
Table Global Meningococcal Disease Treatment Revenue by Product (2014-2019) (Million US$)
Table Global Meningococcal Disease Treatment Revenue Share by Product (2014-2019)
Figure Global Meningococcal Disease Treatment Revenue Market Share by Product (2014-2019)
Figure Global Meningococcal Disease Treatment Revenue Market Share by Product in 2018
Table Meningococcal Disease Treatment Price by Product 2014-2019 (USD/Unit)
Table Global Meningococcal Disease Treatment Sales by End User (2014-2019) (K Units)
Table Global Meningococcal Disease Treatment Sales Share by End User (2014-2019)
Figure Global Sales Meningococcal Disease Treatment Market Share by End User (2014-2019)
Figure Global Sales Meningococcal Disease Treatment Market Share by End User in 2018
Figure North America Meningococcal Disease Treatment Sales Growth Rate 2014-2019 (K Units)
Figure North America Meningococcal Disease Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table North America Meningococcal Disease Treatment Sales by Countries (2014-2019) (K Units)
Table North America Meningococcal Disease Treatment Sales Market Share by Countries (2014-2019)
Figure 2018 North America Meningococcal Disease Treatment Sales Market Share by Countries
Table North America Meningococcal Disease Treatment Revenue by Countries (2014-2019) (Million US$)
Table North America Meningococcal Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Meningococcal Disease Treatment Revenue Market Share by Countries
Figure United States Meningococcal Disease Treatment Sales Growth Rate (2014-2019) (K Units)
Figure United States Meningococcal Disease Treatment Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Meningococcal Disease Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Canada Meningococcal Disease Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Meningococcal Disease Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Meningococcal Disease Treatment Revenue Growth Rate (2014-2019) (Million US$)
Table North America Meningococcal Disease Treatment Sales by Product (2014-2019) (K Units)
Table North America Meningococcal Disease Treatment Sales Market Share by Product (2014-2019)
Figure 2018 North America Meningococcal Disease Treatment Market Share by Product
Table North America Meningococcal Disease Treatment Sales by End User (2014-2019) (K Units)
Table North America Meningococcal Disease Treatment Sales Market Share by End User (2014-2019)
Figure 2018 North America Meningococcal Disease Treatment Market Share by End User
Figure Europe Meningococcal Disease Treatment Sales Growth Rate 2014-2019 (K Units)
Figure Europe Meningococcal Disease Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Meningococcal Disease Treatment Sales by Countries (2014-2019) (K Units)
Table Europe Meningococcal Disease Treatment Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Meningococcal Disease Treatment Sales Market Share by Countries
Table Europe Meningococcal Disease Treatment Revenue by Countries (2014-2019) (Million US$)
Table Europe Meningococcal Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Meningococcal Disease Treatment Revenue Market Share by Countries
Figure Germany Meningococcal Disease Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Germany Meningococcal Disease Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure France Meningococcal Disease Treatment Sales Growth Rate (2014-2019) (K Units)
Figure France Meningococcal Disease Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Meningococcal Disease Treatment Sales Growth Rate (2014-2019) (K Units)
Figure UK Meningococcal Disease Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Meningococcal Disease Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Italy Meningococcal Disease Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Meningococcal Disease Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Russia Meningococcal Disease Treatment Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Meningococcal Disease Treatment Sales by Product (2014-2019) (K Units)
Table Europe Meningococcal Disease Treatment Sales Market Share by Product (2014-2019)
Figure 2018 Europe Meningococcal Disease Treatment Market Share by Product
Table Europe Meningococcal Disease Treatment Sales by End User (2014-2019) (K Units)
Table Europe Meningococcal Disease Treatment Sales Market Share by End User (2014-2019)
Figure 2018 Europe Meningococcal Disease Treatment Market Share by End User
Figure Asia Pacific Meningococcal Disease Treatment Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Meningococcal Disease Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Meningococcal Disease Treatment Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Meningococcal Disease Treatment Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Meningococcal Disease Treatment Sales Market Share by Countries
Table Asia Pacific Meningococcal Disease Treatment Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Meningococcal Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Meningococcal Disease Treatment Revenue Market Share by Countries
Figure China Meningococcal Disease Treatment Sales Growth Rate (2014-2019) (K Units)
Figure China Meningococcal Disease Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Meningococcal Disease Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Japan Meningococcal Disease Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Meningococcal Disease Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Korea Meningococcal Disease Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure India Meningococcal Disease Treatment Sales Growth Rate (2014-2019) (K Units)
Figure India Meningococcal Disease Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Meningococcal Disease Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Australia Meningococcal Disease Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Meningococcal Disease Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Meningococcal Disease Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Meningococcal Disease Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Meningococcal Disease Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Meningococcal Disease Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Meningococcal Disease Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Meningococcal Disease Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Meningococcal Disease Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Meningococcal Disease Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Meningococcal Disease Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Meningococcal Disease Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Meningococcal Disease Treatment Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Meningococcal Disease Treatment Sales by Product (2014-2019) (K Units)
Table Asia Pacific Meningococcal Disease Treatment Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Meningococcal Disease Treatment Market Share by Product
Table Asia Pacific Meningococcal Disease Treatment Sales by End User (2014-2019) (K Units)
Table Asia Pacific Meningococcal Disease Treatment Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Meningococcal Disease Treatment Market Share by End User
Figure Central & South America Meningococcal Disease Treatment Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Meningococcal Disease Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Meningococcal Disease Treatment Sales by Countries (2014-2019) (K Units)
Table Central & South America Meningococcal Disease Treatment Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Meningococcal Disease Treatment Sales Market Share by Countries
Table Central & South America Meningococcal Disease Treatment Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Meningococcal Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Meningococcal Disease Treatment Revenue Market Share by Countries
Figure Brazil Meningococcal Disease Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Meningococcal Disease Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Meningococcal Disease Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Meningococcal Disease Treatment Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Meningococcal Disease Treatment Sales by Product (2014-2019) (K Units)
Table Central & South America Meningococcal Disease Treatment Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Meningococcal Disease Treatment Market Share by Product
Table Central & South America Meningococcal Disease Treatment Sales by End User (2014-2019) (K Units)
Table Central & South America Meningococcal Disease Treatment Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Meningococcal Disease Treatment Market Share by End User
Figure Middle East and Africa Meningococcal Disease Treatment Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Meningococcal Disease Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Meningococcal Disease Treatment Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Meningococcal Disease Treatment Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Meningococcal Disease Treatment Sales Market Share by Countries
Table Middle East and Africa Meningococcal Disease Treatment Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Meningococcal Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Meningococcal Disease Treatment Revenue Market Share by Countries
Figure GCC Countries Meningococcal Disease Treatment Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Meningococcal Disease Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Meningococcal Disease Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Meningococcal Disease Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Meningococcal Disease Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Meningococcal Disease Treatment Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Meningococcal Disease Treatment Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Meningococcal Disease Treatment Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Meningococcal Disease Treatment Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Meningococcal Disease Treatment Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Meningococcal Disease Treatment Market Share by Product
Table Middle East and Africa Meningococcal Disease Treatment Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Meningococcal Disease Treatment Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Meningococcal Disease Treatment Market Share by End User
Table Pfizer Company Details
Table Pfizer Meningococcal Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Meningococcal Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table Sanofi Pasteur Company Details
Table Sanofi Pasteur Meningococcal Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Pasteur Recent Development
Table Novartis Company Details
Table Novartis Meningococcal Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Global Meningococcal Disease Treatment Sales Forecast by Regions 2019-2025 (K Units)
Table Global Meningococcal Disease Treatment Sales Market Share Forecast by Regions 2019-2025
Table Global Meningococcal Disease Treatment Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Meningococcal Disease Treatment Revenue Market Share Forecast by Regions 2019-2025
Table Global Meningococcal Disease Treatment Sales Forecast by Product 2019-2025 (K Units)
Table Global Meningococcal Disease Treatment Sales Market Share Forecast by Product 2019-2025
Table Global Meningococcal Disease Treatment Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Meningococcal Disease Treatment Revenue Market Share Forecast by Product 2019-2025
Table Global Meningococcal Disease Treatment Sales Forecast by End User 2019-2025 (K Units)
Table Global Meningococcal Disease Treatment Sales Market Share Forecast by End User 2019-2025
Figure North America Meningococcal Disease Treatment Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Meningococcal Disease Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Meningococcal Disease Treatment Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Meningococcal Disease Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Meningococcal Disease Treatment Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Meningococcal Disease Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Meningococcal Disease Treatment Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Meningococcal Disease Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Meningococcal Disease Treatment Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Meningococcal Disease Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Meningococcal Disease Treatment Value Chain
Table Meningococcal Disease Treatment Customers List
Table Meningococcal Disease Treatment Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
髄膜炎菌コンジュゲートの世界市場：市場規模・現状・予測 Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It's a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meni…- クラッベ病治療の世界市場：市場規模・現状・予測 Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…
- ウシ呼吸器病治療の世界市場：市場規模・現状・予測 Bovine respiratory disease (BRD) is a multifactorial and complex disorder caused due to combination of more than one microbial pathogens, impaired host immunity, inadequate housing conditions, and environmental factors. The major factor leading to bovine respiratory diseases are host factors, enviro…
- ニューカッスル病治療の世界市場：市場規模・現状・予測 Newcastle Disease is a highly contagious disease of avian species especially poultry caused by avian Paramyxovirus type 1 (APMV-1).The North America is dominating and contributed the leading shares to the global Newcastle Disease Treatment market in terms of revenue and expected to register a signif…
- 感染症治療の世界市場：市場規模・現状・予測 Treatment for Infectious Diseases. Treatment of viral infections such as HIV involves patient care and moral support including antiretroviral therapy. Bacterial infections can be treated by administering antibiotics to the patients.In 2018, the global Infectious Disease Treatment market size was xx …